| Similar Articles |
|---|
 |
The Motley Fool
August 25, 2010
Brian Orelli |
Shares Soar! That'll Help Investors Sleep Better Tonight. Somaxon finds a marketing partner for its insomnia drug.   |
The Motley Fool
June 9, 2011
Brian Orelli |
Get Out of Here! $0.5 Million to License a Drug? Somaxon licenses rights to Silenor in Canada, South America, and Africa to Paladin. |
The Motley Fool
August 4, 2011
Sean Williams |
Somaxon's Bore of a Quarter Silenor sales fly out of the gate like molasses in winter. |
The Motley Fool
July 28, 2010
Jordan DiPietro |
3 Biotechs on Your Radar Screen It's not easy keeping track of all the drugs coming in and out of the development pipeline, but if you can stay up to date, you often have an advantage |
The Motley Fool
November 9, 2006
Todd Wenning |
The Best Blue Chip for 2007: Procter & Gamble Investors, this omnipotent consumer staples firm is the best blue chip in the market. |
The Motley Fool
July 16, 2010
Sean Sun |
Stock Cheat Sheet: Procter & Gamble If you're new to Procter & Gamble, consider this your cheat sheet to get introduced to the consumer products giant. |
The Motley Fool
January 31, 2011
Andrew Bond |
A Consumer Giant That's on the Cutting Edge Procter & Gamble's innovation comes from many sources. |
The Motley Fool
April 13, 2006
John Reeves |
A Foolish Baby Shower: Procter & Gamble Few stocks have performed as well over the long term as Procter & Gamble. Clearly, this company is built to last. Investors, take note. |
The Motley Fool
August 31, 2010
Matt Koppenheffer |
How Much Is Procter & Gamble Worth? Is Procter & Gamble's stock on sale? |
The Motley Fool
February 27, 2008
Colleen Paulson |
Making the Tough Decisions Delivering double-digit toothpaste and soap growth means that Procter & Gamble must be meticulous about cost control, and P&G has signaled once again that it will proactively manage its business to success. |
The Motley Fool
December 28, 2006
Michael Leibert |
Fool on the Street: P&G Still Going Strong Investors who believe that the consumer goods giant can achieve organic sales growth of 4% to 7% over the next few years might consider the current share price to be an attractive entry point to own a stake in an industry leader. |
The Motley Fool
January 28, 2011
Matt Koppenheffer |
Procter & Gamble Shareholders Need Some Cheer Shares of Procter & Gamble take a dip after it announced fourth-quarter results. |
The Motley Fool
July 27, 2010
Anand Chokkavelu |
5 Stocks to Buy Before Apple Consider these five first. |
